| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 86.9 | 120.3 | 94.2 |
| Other income | 1.0 | 0.7 | 0.9 |
| Total income | 87.9 | 121.0 | 95.1 |
| Profit before exceptional items & tax | 5.5 | 3.7 | 4.0 |
| Exceptional items | -0.2 | 0.3 | 0.0 |
| Profit before tax | 5.3 | 4.0 | 4.0 |
| Net profit | 3.7 | 2.8 | 2.8 |
| Operating margin | 6.0% | 3.3% | 4.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +32.10% |
|---|---|
| Net profit, quarter on quarter | +32.10% |
| Revenue, year on year | -7.70% |
NSE results filing, NSE: CLSL. Figures extracted from the filing.
Crop Life Science Ltd: key numbers
- Share price
- ₹66.50
- Market cap
- ₹114.0 Cr
- Revenue (annual)
- ₹207.2 Cr
- Net profit (annual)
- ₹6.64 Cr
- P/E (TTM)
- 17.2×Sector 37.5×
- Promoter holding
- 70.01%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Crop Life Science Ltd
All →Crop Life Science Management Change
Crop Life Science Ltd. appointed Mr. Alpeshbhai Gordhanbhai Vaghasiya as an Independent Director. This appointment was approved by shareholders at the 20th Annual General Meeting.
Crop Life Science Annual General Meeting
Crop Life Science Limited held its 20th Annual General Meeting on September 23, 2026. The proceedings covered ordinary and special business resolutions for the shareholders.
Crop Life Science Annual General Meeting
Crop Life Science Limited dispatched letters to non-email registered shareholders providing the web-link for the FY 2025-26 Annual Report. The 20th AGM is scheduled for September 23, 2026.